Abstract Number: 342 • 2019 ACR/ARP Annual Meeting
Rheumatologist Care Is Associated with Fewer Emergency Room Visits by Persons with Gout
Background/Purpose: Gout is one of the most common inflammatory arthropathies, although care of gout patients is not always optimal. By searching a large administrative data…Abstract Number: 343 • 2019 ACR/ARP Annual Meeting
Emergency Department Length of Stay in Patients with Acute Gout
Background/Purpose: Emergency department (ED) visits for acute gout increased by approximately 20% between 2006 and 2014 in the United States. (1) Reducing ED length of stay…Abstract Number: 346 • 2019 ACR/ARP Annual Meeting
Subtypes of Gout Based on Comorbidity Patterns Among Black Patients in the US General Population – Cluster Analysis of the National Health and Nutrition Examination Survey 2007-2016
Background/Purpose: Gout is a very prevalent condition associated with many metabolic and cardiorenal comorbidities. A few studies have investigated the comorbidity subtypes of gout patients…Abstract Number: 348 • 2019 ACR/ARP Annual Meeting
Patterns of Newer Gout Medication Use in a U.S. Electronic Health Record-Based Registry
Background/Purpose: A variety of newer gout therapies have been introduced in recent years, some with potential safety concerns. However, uptake of these therapies and associated…Abstract Number: 349 • 2019 ACR/ARP Annual Meeting
Carotid Atherosclerosis and Sonographic Signs of Urate Crystal Deposits in Patients with Gout: An Association Study
Background/Purpose: Carotid subclinical atherosclerosis is prevalent in patients with gout, although poorly predicted by cardiovascular risk assessment tools. Gout itself is deemed to contribute to…Abstract Number: 353 • 2019 ACR/ARP Annual Meeting
Allopurinol Use and Type 2 Diabetes Incidence Among Patients with Gout: A VA Cohort Study
Background/Purpose: Several studies implicate gout and/or xanthine oxidase activity as risk factors for type 2 diabetes. However, no studies have directly evaluated the effect of…Abstract Number: 355 • 2019 ACR/ARP Annual Meeting
Comparative Risk of Cardiovascular Events in US Veterans with Gout Treated with Febuxostat versus Allopurinol
Background/Purpose: Gout is the most common inflammatory arthritis and is particularly common among veterans. Recent studies, a randomized controlled trial (CARES, White et al. NEJM…Abstract Number: 356 • 2019 ACR/ARP Annual Meeting
Gout Flares Become Infrequent During a Treat-to-target Strategy over One Year: Data from the NOR-Gout Study
Background/Purpose: Urate lowering therapy (ULT) is expected to prevent new gout flares. Treat-to-target ULT is however often not performed, and more evidence on how often…Abstract Number: 358 • 2019 ACR/ARP Annual Meeting
Emergency Department Encounters in a Large US Payer Database: Tophaceous versus Non-tophaceous Gout Patients
Background/Purpose: From 2006 to 2012, gout was the primary indication for ~0.2% of all emergency department visits for adults, as reported in the Nationwide Emergency…Abstract Number: 360 • 2019 ACR/ARP Annual Meeting
Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol Is Very Cost Effective: A Health Economic Analysis
Background/Purpose: Prophylaxis of acute gout flares when commencing urate lowering therapy is recommended by international guidelines. Whether this is a cost-effective intervention is currently unknown.…Abstract Number: 361 • 2019 ACR/ARP Annual Meeting
Frequency of Allopurinol Dose Reduction in Hospitalized Patients with Gout Flares
Background/Purpose: It is a common misconception that allopurinol should either be held or reduced during gout flares and renal insufficiency. However, current guidelines recommend the…Abstract Number: 362 • 2019 ACR/ARP Annual Meeting
Methods to Efficiently Recruit Minority Patients with Gout for Clinic-Based Registries
Background/Purpose: Gout is frequently misdiagnosed and/or miscoded, making approaches to identifying eligible patients for observational and interventional studies more challenging. Ethnic and racial minorities are…Abstract Number: 363 • 2019 ACR/ARP Annual Meeting
Efficacy and Outcomes of Telephone-Based Management Program in Patients with Gout
Background/Purpose: Gout is the most common inflammatory arthritis in the US, and causes significant morbidity. Despite published guidelines and available effective treatment, management remains suboptimal,…Abstract Number: 365 • 2019 ACR/ARP Annual Meeting
Classifying Pseudogout Using Machine Learning Approaches with Electronic Health Record Data
Background/Purpose: Identifying pseudogout in large administrative datasets has been difficult due to lack of specific billing codes for this acute subtype of calcium pyrophosphate (CPP)…Abstract Number: 898 • 2019 ACR/ARP Annual Meeting
Ultrasound Demonstrates Rapid Reduction of Crystal Depositions During a Treat-to-target Approach in Gout Patients: Two-year Results from a Longitudinal, Observational Study (NOR-GOUT)
Background/Purpose: Ultrasound is sensitive for detecting depositions of uric monosodium urate (MSU) crystals and is included in the ACR/EULAR classification criteria for gout. The OMERACT…
Simple Search Results
Didn't find what you were looking for? Try the Advanced Search »
Didn't find what you were looking for? Try the Advanced Search »